This study is completed in Australia, in New Zealand, in China, .... It is testing paliperidone palmitate for schizophrenia.
SchizophreniaDrugFrom 18 Years to 50 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Paliperidone Palmitate Administered may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Paliperidone Palmitate Administered, attend study visits with the research team. The registry lists locations in Australia, in China, and in Malaysia.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Australia · 9 sites
Dandenong
Dandenong
Site status: Not listed — confirm with the team
Elizabeth Vale
Elizabeth Vale
Site status: Not listed — confirm with the team
Epping
Epping
Site status: Not listed — confirm with the team
Frankston
Frankston
Site status: Not listed — confirm with the team
Glenside
Glenside
Site status: Not listed — confirm with the team
Heidelberg
Heidelberg
Site status: Not listed — confirm with the team
Melbourne
Melbourne
Site status: Not listed — confirm with the team
Prahran
Prahran
Site status: Not listed — confirm with the team
Westmead
Westmead
Site status: Not listed — confirm with the team
China · 5 sites
Beijing
Beijing
Site status: Not listed — confirm with the team
Guangzhou
Guangzhou
Site status: Not listed — confirm with the team
Nanjing
Nanjing
Site status: Not listed — confirm with the team
Shanghai
Shanghai
Site status: Not listed — confirm with the team
Xi'an
Xi'an
Site status: Not listed — confirm with the team
Hong Kong · 1 site
Hong Kong
Hong Kong
Site status: Not listed — confirm with the team
Malaysia · 7 sites
Johor Bahru
Johor Bahru
Site status: Not listed — confirm with the team
Kota Bharu
Kota Bharu
Site status: Not listed — confirm with the team
Kota Kinabalu
Kota Kinabalu
Site status: Not listed — confirm with the team
Kuala Lumpur
Kuala Lumpur
Site status: Not listed — confirm with the team
Kuching
Kuching
Site status: Not listed — confirm with the team
Tanjong Rambutan
Tanjong Rambutan
Site status: Not listed — confirm with the team
Terengganu
Terengganu
Site status: Not listed — confirm with the team
New Zealand · 1 site
Auckland
Auckland
Site status: Not listed — confirm with the team
Philippines · 2 sites
Pasig
Pasig
Site status: Not listed — confirm with the team
Pasig National Capitol Region
Pasig National Capitol Region
Site status: Not listed — confirm with the team
South Korea · 7 sites
Busan
Busan
Site status: Not listed — confirm with the team
Daegu
Daegu
Site status: Not listed — confirm with the team
Daejeon
Daejeon
Site status: Not listed — confirm with the team
Gwangju
Gwangju
Site status: Not listed — confirm with the team
Gyeonggi-do
Gyeonggi-do
Site status: Not listed — confirm with the team
Incheon
Incheon
Site status: Not listed — confirm with the team
Seoul
Seoul
Site status: Not listed — confirm with the team
Taiwan · 5 sites
Changhua County
Changhua County
Site status: Not listed — confirm with the team
Kaohsiung City
Kaohsiung City
Site status: Not listed — confirm with the team
Taichung
Taichung
Site status: Not listed — confirm with the team
Tainan
Tainan
Site status: Not listed — confirm with the team
Taipei
Taipei
Site status: Not listed — confirm with the team
Thailand · 4 sites
Bangkok
Bangkok
Site status: Not listed — confirm with the team
Khon Kaen
Khon Kaen
Site status: Not listed — confirm with the team
Songkhla
Songkhla
Site status: Not listed — confirm with the team
Ubon Ratchathani
Ubon Ratchathani
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01051531. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Paliperidone palmitate. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Janssen Research & Development, LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
